FDA drug guidance may threaten compliance for “literally every LTC facility,” pharmacy group says
New repackaging guidelines from the Food and Drug Administration could place “literally every LTC facility and associated pharmacy in America” at risk of failing to meet Medicare and Medicaid regulatory requirements, a senior care executive said last week.
During a June 6 FDA listening session, Senior Care Pharmacy Coalition President and CEO Alan Rosenbloom said the added regulations under the Drug Quality and Security Act could place the health and safety of LTC patients at risk.
Under the new policy, repacking drug products would become subject to a variety of different regulations, including repackaging timeframes and where the packaging can take place.
In a previous letter sent to the FDA by Rosenbloom in December 2015, he said the DQSA provisions would force pharmacies and regulatory reviewers to severely alter their policies, placing an increased financial burden on the repacking process.
He expressed these same concerns in the recent session, saying the provisions would “materially alter long-standing LTC pharmacy practices and procedures.”
He also said other organizations in the industry share his opinion.
Due to the high number of comments the FDA had received from those who would be affected by the provisions, Rosenbloom suggested an additional listening session take place before the guidelines were finalized.
Click here to see the original article on the McKnight’s website.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.